YAP1 silencing enhances cisplatin efficacy in lung adenocarcinoma via activating mitochondrial apoptosis
Biomaterials Advances · 2026-09 · 186 · 214927
DOI: 10.1016/j.bioadv.2026.214927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomaterials Advances, 2026-09. Verfasst von Renfeng Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Optoelectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technol…. Hauptthemen laut MEDLINE: Cisplatin, Apoptosis, Transcription Factors, Mitochondria. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fujian Provincial Health Commission, Natural Science Foundation of Fujian Province.
Abstract (Originalsprache)
Lung adenocarcinoma (LUAD) remains one of the leading causes of cancer-related deaths worldwide, and cisplatin (DDP) resistance severely limits the efficacy of first-line chemotherapy. Extracellular matrix (ECM) stiffening is a hallmark of solid tumors, yet how it modulates chemosensitivity remains unclear. This study demonstrates that matrix stiffness activates the mechanosensor YAP1 in lung adenocarcinoma, which in turn establishes an apoptosis-refractory state by upregulating Bcl2 and downregulating Bax. Functional experiments establish the YAP1-Bax axis as the core pathway, while clinical correlation analysis reveals that YAP1 expression significantly predicts poor post-chemotherapy survival. Our findings reveal a mechanism by which mechanical cues desensitize mitochondrial apoptosis through YAP1-driven transcriptional reprogramming, providing both new insights into chemoresistance mechanisms and a potential biomarker for treatment response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Optoelectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, 350007, China.
- Department of Pathology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China; Department of Pathology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fuji…
- Department of Pathology, the First Affiliated Hospital of Fujian Medical University, Fuzhou, 350005, China.
- Key Laboratory of Optoelectronic Science and Technology for Medicine of Ministry of Education, Fujian Provincial Key Laboratory for Photonics Technology, Fujian Normal University, Fuzhou, 350007, China. Electronic addre…
Förderung
- National Natural Science Foundation of China
- Fujian Provincial Health Commission
- Natural Science Foundation of Fujian Province
Zitieren
APA
Xu, R., Zeng, S., Zhang, T., Wu, J., Tang, J., Yang, H., & Gao, F. (2026). YAP1 silencing enhances cisplatin efficacy in lung adenocarcinoma via activating mitochondrial apoptosis. Biomaterials Advances, 186, 214927. https://doi.org/10.1016/j.bioadv.2026.214927
Vancouver
Xu R, Zeng S, Zhang T, Wu J, Tang J, Yang H, et al. YAP1 silencing enhances cisplatin efficacy in lung adenocarcinoma via activating mitochondrial apoptosis. Biomaterials Advances. 2026;186:214927. doi:10.1016/j.bioadv.2026.214927
BibTeX
@article{Xu2026,
author = {Xu, Renfeng and Zeng, Saifan and Zhang, Ting and Wu, Jingjing and Tang, Juan and Yang, Hongqin and Gao, Feng},
title = {YAP1 silencing enhances cisplatin efficacy in lung adenocarcinoma via activating mitochondrial apoptosis},
journal = {Biomaterials Advances},
year = {2026},
volume = {186},
pages = {214927},
doi = {10.1016/j.bioadv.2026.214927}
}
EUVIMED